PharmAla Issues Q3 Financial Statements and AGM Update

PharmAla files Q3 financial statements, highlighting improved financial performance compared to 2025, and provides an update on motions passed at their AGM

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.